Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
Mo | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31, 2025 | 119 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
31.03. | eyonis LCS, Median Technologies' AI-Powered Software as a Medical Device for Lung Cancer Screening, Confirmed Efficacy and Safety in RELIVE Pivotal Study | 211 | Business Wire | All secondary endpoints required to support eyonis LCS' intended use and desired marketing claims achieved in RELIVE
eyonis LCS previously met primary endpoint, achieving statistically... ► Artikel lesen | |
07.03. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of February 28, 2025 | 306 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares
... ► Artikel lesen | |
03.03. | Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders' Extraordinary General Meeting on March 20, 2025 | 228 | Business Wire | Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT, PEA/PME scheme eligible, "Median" or "The Company") are invited to participate in the Shareholders' Extraordinary... ► Artikel lesen | |
26.02. | Median Technologies to Present at TD Cowen's 45th Annual Health Care Conference | 232 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "The Company"), a leading developer of eyonis, a suite of artificial intelligence (AI) powered Software... ► Artikel lesen | |
24.02. | Median Technologies to Showcase Its Artificial Intelligence Software as a Medical Device for Lung Cancer Screening, eyonis LCS, at the European Congress of Radiology | 236 | Business Wire | Industry presentation at the AI Theatre: "eyonis LCS: Pioneering AI/ML Software as a Medical Device Redefining the Future of Lung Cancer Screening
Median eyonis teams will be at booth AI-18... ► Artikel lesen | |
11.02. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2025 | 250 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
05.02. | Median Technologies Gives Update on Drawdowns of the Iris Equity Line | 276 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME scheme eligible), a leading developer of eyonis, a suite of artificial intelligence (AI) powered Software as a Medical Device... ► Artikel lesen | |
03.02. | Median Technologies: eyonis Lung Cancer Screening (LCS) Meets Primary Endpoint in RELIVE Clinical Trial, the Final Pivotal Study Required for Regulatory Submissions | 271 | Business Wire | Primary endpoint met with statistical significance (p=0.027) in pivotal RELIVE trial of eyonis LCS, Median's AI/ML-based Software as a Medical Device for lung cancer screening
eyonis LCS... ► Artikel lesen | |
31.01. | Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook | 341 | Business Wire | H2 2024 revenue €12.0 million up 10.2% compared to H2 2023
FY 2024 revenue €22.9 million up 3.3% compared to 2023
Growing order backlog at €71.0 million, as of December 31, 2024... ► Artikel lesen | |
24.01. | Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis regulatory filings and commercialization in U.S. and EU | 395 | Business Wire | Repayment of 2020 EIB loan to be rescheduled to October 2025 from April
New €37.5 million 2025 EIB loan under appraisal, final authorization stage
New up to €10 million equity line... ► Artikel lesen | |
14.01. | Median Technologies: Financial Communications Schedule for the First Half of 2025 | 423 | Business Wire | Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible), announces the publication date for its 2024 results:
Publication
Date
... ► Artikel lesen | |
09.01. | Half Year Median Technologies Liquidity Contract Statement | 290 | Business Wire | Regulatory News:
Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, "Median" or "the Company") to TP ICAP (Europe), the following resources were... ► Artikel lesen | |
08.01. | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of December 31st, 2024 | 214 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
11.12.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of November 30th, 2024 | 316 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
26.11.24 | Median Technologies to Showcase AI-Powered Lung Cancer Diagnostic eyonis LCS at the Radiological Society of North America (RSNA) 2024 | 95 | Business Wire | Peer-reviewed scientific e-poster: "Performances of an End-to-End AI/ML CADe/CADx SaMD for Nodule Detection and Characterization in Lung Cancer Screening on an Independent Cohort Compared to Radiologists."... ► Artikel lesen | |
12.11.24 | Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31st, 2024 | 313 | Business Wire | Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations.
Regulatory News:
Median Technologies (Paris:ALMDT):
Total number of shares... ► Artikel lesen | |
07.11.24 | Median Technologies Hosted Insightful Key Opinion Leader (KOL) Webinar on eyonis Lung Cancer Screening (LCS) REALITY Data | 413 | Business Wire | Two globally leading pulmonologists reviewed REALITY data, AI and the potential impact on lung cancer screening
Replay in English is available on the link here
A French subtitled... ► Artikel lesen | |
30.10.24 | Median Technologies to Host Key Opinion Leader (KOL) Webinar on AI and Lung Cancer Screening | 335 | Business Wire | Webinar to focus on the eyonis Lung Cancer Screening (LCS) REALITY data
November 7, 2024 1:30 pm CET 7:30 am ET Registration link
Regulatory News:
Median Technologies (FR0011049824, ALMDT... ► Artikel lesen | |
24.10.24 | Median Technologies Reports 2024 Q3 Operational and Financial Update and 2024 Half-Year Results | 386 | Business Wire | eyonis LCS pivotal REALITY study met all primary and secondary endpoints
A webcast including Key Opinion Leaders will be held on November 7, 2024, to discuss the REALITY study results
... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PALANTIR TECHNOLOGIES | 72,21 | +1,28 % | Wall Street gelingt Turnaround! Kommt die Wende? Tesla | Nvidia | Bitcoin | Palantir | Nach einem schwachen Start in den Handel hat sich die Wall Street am Montag deutlich erholt. Der Dow Jones schloss 1,0 Prozent höher. Zwar konnte der technologielastige Nasdaq die Verlustzone nicht... ► Artikel lesen | |
TEAMVIEWER | 11,500 | +4,55 % | TeamViewer Aktie: Starke Position im Markt! | Die TeamViewer SE intensiviert ihre Bemühungen im Bereich innovativer 3D-Lösungen für die Industrie 4.0. Der Anbieter von Remote-Connectivity-Lösungen schloss am Dienstag mit einem Kurs von 12,16 Euro... ► Artikel lesen | |
ORACLE | 114,72 | -1,51 % | AMD: Oracle setzt auf die EPYC-Prozessoren der fünften Generation! | ||
SHOPIFY | 71,33 | -1,26 % | Vor jeder Neueinstellung: Shopify-CEO verlangt Beweis, dass KI den Job nicht besser erledigen kann | Bei Shopify gelten ab sofort neue Regeln für Stellenausschreibungen. Laut dem CEO des Unternehmens dürfen diese überhaupt erst freigegeben werden, wenn die Stelle nicht von einer KI erledigt werden... ► Artikel lesen | |
CROWDSTRIKE | 302,00 | +1,65 % | CrowdStrike Aktie: Motivierende Wirtschaftsprognosen! | Der Cybersicherheitsspezialist verzeichnet Kurszuwächse und erhält positive Analysteneinschätzungen trotz rechtlicher Herausforderungen nach dem globalen Systemausfall. Die CrowdStrike Holdings verzeichnet... ► Artikel lesen | |
ZOOM COMMUNICATIONS | 61,97 | -0,64 % | Vizrt partners with Zoom to break new ground in the evolution of video communications | The partnership sets the stage for future innovation, starting with Zoom integration into TriCaster for seamless remote production
BERGEN, Norway, April 7, 2025 /PRNewswire/ -- Vizrt... ► Artikel lesen | |
ATOSS SOFTWARE | 123,60 | +3,17 % | Atoss Software Aktie: Ist die Unsicherheit gerechtfertigt? | Workforce-Management-Spezialist verzeichnet erhebliche Wertverluste im Jahresvergleich bei moderater Erholung in 2025, während strukturelle Markttrends Wachstumschancen bieten Atoss Software Aktie:... ► Artikel lesen | |
D-WAVE QUANTUM | 5,774 | -4,59 % | Hype-Aktien: D-Wave Quantum, Rigetti & Co: Quantenhype auserzählt? | © Foto: Marijan Murat - dpaNachdem Quantencomputing-Aktien im letzten Jahr in schwindelerregende Höhen katapultiert wurden, scheint die Wall Street nun nicht mehr an der Quantenwachstumsstory interessiert... ► Artikel lesen | |
RIOT PLATFORMS | 6,034 | -7,18 % | Riot Platforms, Inc.: Riot Announces March 2025 Production and Operations Updates | Riot Produces 533 Bitcoin in March 2025 CASTLE ROCK, Colo., April 3, 2025 /PRNewswire/ -- Riot Platforms, Inc. (NASDAQ: RIOT) ("Riot" or "the Company"), an industry leader in vertically... ► Artikel lesen | |
FASTLY | 4,594 | -2,36 % | Fastly: Kaum Wachstum, hohe Verluste belasten | SAN FRANCISCO, Kalifornien (IT-Times) - Fastly hat seine Ergebnisse für das vierte Quartal des Geschäftsjahres 2024 veröffentlicht und noch ein kleines Umsatzwachstum verzeichnet. Fastly Aktie: QuartalsergebnisDer... ► Artikel lesen | |
VEEVA SYSTEMS | 200,90 | +2,08 % | Veeva Systems: Veeva Announces Research Site Clinical Trial Management System | Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors
BARCELONA, Spain, April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced... ► Artikel lesen | |
BRAINCHIP | 0,106 | -0,19 % | BRAINCHIP HOLDINGS LTD: Notification regarding unquoted securities - BRN | ||
GEN DIGITAL | 22,200 | +1,83 % | Kursgewinne für den Anteilsschein von Gen Digital (25,6071 €) | An der US-amerikanischen Börse notiert der Anteilsschein von Gen Digital derzeit ein wenig fester. Zuletzt zahlten Investoren für das Papier 27,95 US-Dollar. Für die Gen Digital-Aktie steht gegenwärtig... ► Artikel lesen | |
ATLASSIAN | 170,00 | -0,57 % | Massive Kursverluste für die Atlassian-Aktie (172,7456 €) | Im Wertpapierhandel fällt derzeit das Wertpapier von Atlassian negativ auf. Der Kurs des Anteilsscheins sackt kräftig ab. Kein guter Tag bislang für Inhaber von Atlassian: Das Wertpapier weist gegenwärtig... ► Artikel lesen | |
VERSES AI | 3,240 | -9,03 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA 27.03.2025 | The following instruments on XETRA do have their first trading 27.03.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.03.2025
Aktien
1 CA4013392051 Guardian Capital Group... ► Artikel lesen |